The importance of racial diversity in clinical trials
https://www.facingourrisk.org/XRAY/racial-diversity-in-cancer-drug-clinical-trials
Full article: https://www.propublica.org/article/black-patients-miss-out-on-promising-cancer-drugs
This article by journalists Caroline Chen and Riley Wong looks at racial disparities between participation in clinical trials and the population of people with cancer. (11/6/18)
Este artículo está disponible en español.
Questions To Ask Your Health Care Provider
- Do I qualify for any clinical trials that are currently enrolling?
- What are the risks and benefits of participating in a clinical trial?
- What is known about the cancer drugs I am taking for people with my racial or ethnic background?
Open Clinical Trials
The following clinical research studies focus on addressing health disparities in cancer.
- NCT04854304: Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts. This study looks at how effectively a FAST breast MRI can successfully detect breast cancer in Black women with dense breasts.
- NCT03640208: Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African Americans. This research studies a community-based intervention to educate and overcome barriers to screening among African Americans who are age 45 older with no personal or family history of colorectal cancer or inflammatory bowel disease.
- NCT04392050: A Community-Based Educational Intervention to Improve Colorectal Cancer Screening. This study looks at what makes it easy or difficult for underserved populations to have colorectal cancer screening with a focus on African American, Latinx and Asian people.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.